Abstract:Background Long intergenic non-protein coding RNA 1140 (LINC01140), a long non-coding RNA, is highly expressed in various cancers; however, its biological functions in lung cancer (LC) progression and immune escape are still unclear. Methods Here, to elucidate LINC01140 function, 79 paired LC and paracancerous tissues were collected. LINC01140 expression levels were determined using fluorescence in situ hybridization and qPCR analysis. Cell counting kit-8 (CCK-8) assay and transwell assays were performed. The interaction between microRNAs (miRNAs) and LINC01140 was confirmed using an RNA immunoprecipitation assay. Cytokine-induced killer (CIK) cell phenotypes were analyzed by flow cytometry. Cytokine secretion levels were determined by ELISA. CIK cytotoxicity was assessed by measuring lactate dehydrogenase release. Besides, xenograft tumor mouse models were used to unveil the in vivo function of LINC01140. Results We found that LINC01140 was highly expressed in human LC tissues and cell lines. High LINC01140 levels were associated with poor survival in patients with LC. LINC01140 upregulation promoted the proliferation, migration, and invasion of LC cells through direct interaction with miR-33a-5p and miR-33b-5p, thereby contributing to c-Myc expression and also inhibited cisplatin-induced cell apoptosis. In subcutaneous tumor xenograft mice, LINC01140 knockdown markedly reduced tumor growth and lung metastasis. Additionally, LINC01140 directly repressed miR-377-3 p and miR-155-5 p expression levels, resulting in the upregulation of their common downstream target programmed death-ligand 1 (PD-L1), a crucial target in LC immunotherapy. Notably, we proved that LINC01140 knockdown, along with CIK administration, suppressed the growth of subcutaneous LC xenografts by decreasing PD-L1 expression in severe combined immunodeficient mice. Conclusions Taken together, LINC01140 overexpression protects c-Myc and PD-L1 mRNA from miRNA-mediated inhibition and contributes to the proliferation, migration, invasion, and immune escape of LC cells. These results provide a theoretical basis that LINC01140 is a promising target for LC treatment.

Camp/creb-Regulated LINC00473 Marks LKB1-inactivated Lung Cancer and Mediates Tumor Growth

Upregulation of Long Intergenic Noncoding RNA 00673 Promotes Tumor Proliferation Via LSD1 Interaction and Repression of NCALD in Non-Small-cell Lung Cancer.

Dependency of human and murine LKB1-inactivated lung cancer on aberrant CRTC-CREB activation

LINC00514 facilitates cell proliferation, migration, invasion, and epithelial-mesenchymal transition in non-small cell lung cancer by acting on the Wnt/β-catenin signaling pathway

Non-coding RNA LINC00857 is predictive of poor patient survival and promotes tumor progression via cell cycle regulation in lung cancer

Dependency of LKB1-inactivated lung cancer on aberrant CRTC-CREB activation

Long Intergenic Noncoding RNA 00511 Acts As an Oncogene in Non–small-cell Lung Cancer by Binding to EZH2 and Suppressing P57

LINC81507 act as a competing endogenous RNA of miR-199b-5p to facilitate NSCLC proliferation and metastasis via regulating the CAV1/STAT3 pathway

Identification and Validation of LINC01322 As a Potential Prognostic Biomarker and Oncogene Promoting Tumor Progression in Lung Adenocarcinoma.

LINC00472 suppresses non-small cell lung cancer progression via regulating miR-23a-3p/CCL22 axis

<i>LINC00116</i> Is a Novel Prognostic Biomarker of Nonsmall Cell Lung Cancer

Upregulation of Long Intergenic Non-Coding RNA LINC00326 Inhibits Non-Small Cell Lung Carcinoma Progression by Blocking Wnt/β-catenin Pathway Through Modulating the Mir-657/Dickkopf WNT Signaling Pathway Inhibitor 2 Axis

LINC00941 is a diagnostic biomarker for lung adenocarcinoma and promotes tumorigenesis through cell autophagy

Copy number amplification-activated long non-coding RNA LINC00662 epigenetically inhibits BIK by interacting with EZH2 to regulate tumorigenesis in non-small cell lung cancer

LINC01140 promotes the progression and tumor immune escape in lung cancer by sponging multiple microRNAs

LINC00467: A key oncogenic long non-coding RNA

Long Noncoding RNA LINC00961 Inhibits Cell Proliferation and Induces Cell Apoptosis in Human Non–small Cell Lung Cancer

LINC00467: an oncogenic long noncoding RNA

Long Non-Coding Rna 00312 Regulated by Hoxa5 Inhibits Tumour Proliferation and Promotes Apoptosis in Non-Small Cell Lung Cancer

The Long Noncoding RNA LINC01207 Promotes Proliferation of Lung Adenocarcinoma.

The LINC01260 Functions as a Tumor Suppressor via the miR-562/CYLD/NF-κB Pathway in Non-Small Cell Lung Cancer